We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. Show more
Avidity Biosciences to Participate in Upcoming Investor Conference PR Newswire SAN DIEGO, Nov. 26, 2024 SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a...
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Nov. 21, 2024 SAN DIEGO, Nov. 21, 2024 /PRNewswire/ --Β Avidity Biosciences, Inc...
Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations PR...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.23 | -11.4417094942 | 36.97 | 37.28 | 32.04 | 1335922 | 34.04158757 | CS |
4 | -7.71 | -19.0605686032 | 40.45 | 45.98 | 32.04 | 1130917 | 38.89006076 | CS |
12 | -11.56 | -26.0948081264 | 44.3 | 56 | 32.04 | 1113402 | 43.7098681 | CS |
26 | -6.6 | -16.7768174886 | 39.34 | 56 | 32.04 | 1306219 | 43.27040569 | CS |
52 | 24.01 | 275.028636884 | 8.73 | 56 | 8.37 | 1264217 | 33.12373004 | CS |
156 | 10.68 | 48.413417951 | 22.06 | 56 | 4.825 | 1015383 | 22.00516107 | CS |
260 | 6.24 | 23.5471698113 | 26.5 | 56 | 4.825 | 765329 | 22.39702495 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions